Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors.
Identifieur interne : 000417 ( Main/Exploration ); précédent : 000416; suivant : 000418Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors.
Auteurs : Emma Lindqvist [Suède] ; Madelene Wedin [Suède] ; Mats Fredrikson [Suède] ; Preben Kj Lhede [Suède]Source :
- European journal of obstetrics, gynecology, and reproductive biology [ 1872-7654 ] ; 2017.
Abstract
Lymphedema is one of the least studied complications of cancer treatment and a chronic condition with a substantial impact on health-related quality of life (HQoL). Lymphedema of the legs (LLL) constitutes a common adverse side effect of lymphadenectomy LA in gynecologic cancer treatment. Primary treatment of endometrial cancer (EC) comprises hysterectomy and bilateral salpingo-oophorectomy. Pelvic and para-aortic lymphadenectomy is recommended in prognostic high risk groups of EC. This review summarizes the published literature concerning the prevalence of LLL after treatment for EC, methods used for measuring LLL, risk factors and HQoL impact. The main findings are that the reported prevalence of LLL varies significantly between 0% and 50%. This is due to a lack of a generally accepted standardization of terminology in assessment of lymphedema. The studies use different methods to assess and grade lymphedema and often the methodology used for determining LLL is poorly described and lacks baseline measurement. Lymphadenectomy, number of lymph nodes removed, and radiation therapy seems to increase the risk for LLL. All studies dealing with HQoL show that women with LLL have impaired HQoL. The level of evidence in the published studies is generally low. Consequently it is difficult to make clear-cut conclusions about the true prevalence or determination of risk factors. More prospective longitudinal or randomized trials with LLL as the primary outcome are necessary before conclusions can be drawn regarding prevalence of LLL and risk factor determination in EC. An internationally accepted standardization for terminology and methodology in lymphedema in research is needed.
DOI: 10.1016/j.ejogrb.2017.02.021
PubMed: 28242470
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000340
- to stream PubMed, to step Curation: 000340
- to stream PubMed, to step Checkpoint: 000340
- to stream Ncbi, to step Merge: 008D94
- to stream Ncbi, to step Curation: 008D94
- to stream Ncbi, to step Checkpoint: 008D94
- to stream Main, to step Merge: 000417
- to stream Main, to step Curation: 000417
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors.</title><author><name sortKey="Lindqvist, Emma" sort="Lindqvist, Emma" uniqKey="Lindqvist E" first="Emma" last="Lindqvist">Emma Lindqvist</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, The Highland Hospital, Eksjö, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Obstetrics and Gynecology, The Highland Hospital, Eksjö</wicri:regionArea><wicri:noRegion>Eksjö</wicri:noRegion></affiliation></author><author><name sortKey="Wedin, Madelene" sort="Wedin, Madelene" uniqKey="Wedin M" first="Madelene" last="Wedin">Madelene Wedin</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping</wicri:regionArea><wicri:noRegion>Linköping</wicri:noRegion></affiliation></author><author><name sortKey="Fredrikson, Mats" sort="Fredrikson, Mats" uniqKey="Fredrikson M" first="Mats" last="Fredrikson">Mats Fredrikson</name><affiliation wicri:level="1"><nlm:affiliation>Forum Östergötland, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden; Occupational and Environmental Medicine, Department of Experimental and Clinical Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Forum Östergötland, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden; Occupational and Environmental Medicine, Department of Experimental and Clinical Medicine, Faculty of Health Sciences, Linköping University, Linköping</wicri:regionArea><wicri:noRegion>Linköping</wicri:noRegion></affiliation></author><author><name sortKey="Kj Lhede, Preben" sort="Kj Lhede, Preben" uniqKey="Kj Lhede P" first="Preben" last="Kj Lhede">Preben Kj Lhede</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. Electronic address: Preben.Kjolhede@liu.se.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping</wicri:regionArea><wicri:noRegion>Linköping</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28242470</idno><idno type="pmid">28242470</idno><idno type="doi">10.1016/j.ejogrb.2017.02.021</idno><idno type="wicri:Area/PubMed/Corpus">000340</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000340</idno><idno type="wicri:Area/PubMed/Curation">000340</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000340</idno><idno type="wicri:Area/PubMed/Checkpoint">000340</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000340</idno><idno type="wicri:Area/Ncbi/Merge">008D94</idno><idno type="wicri:Area/Ncbi/Curation">008D94</idno><idno type="wicri:Area/Ncbi/Checkpoint">008D94</idno><idno type="wicri:Area/Main/Merge">000417</idno><idno type="wicri:Area/Main/Curation">000417</idno><idno type="wicri:Area/Main/Exploration">000417</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors.</title><author><name sortKey="Lindqvist, Emma" sort="Lindqvist, Emma" uniqKey="Lindqvist E" first="Emma" last="Lindqvist">Emma Lindqvist</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, The Highland Hospital, Eksjö, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Obstetrics and Gynecology, The Highland Hospital, Eksjö</wicri:regionArea><wicri:noRegion>Eksjö</wicri:noRegion></affiliation></author><author><name sortKey="Wedin, Madelene" sort="Wedin, Madelene" uniqKey="Wedin M" first="Madelene" last="Wedin">Madelene Wedin</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping</wicri:regionArea><wicri:noRegion>Linköping</wicri:noRegion></affiliation></author><author><name sortKey="Fredrikson, Mats" sort="Fredrikson, Mats" uniqKey="Fredrikson M" first="Mats" last="Fredrikson">Mats Fredrikson</name><affiliation wicri:level="1"><nlm:affiliation>Forum Östergötland, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden; Occupational and Environmental Medicine, Department of Experimental and Clinical Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Forum Östergötland, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden; Occupational and Environmental Medicine, Department of Experimental and Clinical Medicine, Faculty of Health Sciences, Linköping University, Linköping</wicri:regionArea><wicri:noRegion>Linköping</wicri:noRegion></affiliation></author><author><name sortKey="Kj Lhede, Preben" sort="Kj Lhede, Preben" uniqKey="Kj Lhede P" first="Preben" last="Kj Lhede">Preben Kj Lhede</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. Electronic address: Preben.Kjolhede@liu.se.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping</wicri:regionArea><wicri:noRegion>Linköping</wicri:noRegion></affiliation></author></analytic><series><title level="j">European journal of obstetrics, gynecology, and reproductive biology</title><idno type="eISSN">1872-7654</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphedema is one of the least studied complications of cancer treatment and a chronic condition with a substantial impact on health-related quality of life (HQoL). Lymphedema of the legs (LLL) constitutes a common adverse side effect of lymphadenectomy LA in gynecologic cancer treatment. Primary treatment of endometrial cancer (EC) comprises hysterectomy and bilateral salpingo-oophorectomy. Pelvic and para-aortic lymphadenectomy is recommended in prognostic high risk groups of EC. This review summarizes the published literature concerning the prevalence of LLL after treatment for EC, methods used for measuring LLL, risk factors and HQoL impact. The main findings are that the reported prevalence of LLL varies significantly between 0% and 50%. This is due to a lack of a generally accepted standardization of terminology in assessment of lymphedema. The studies use different methods to assess and grade lymphedema and often the methodology used for determining LLL is poorly described and lacks baseline measurement. Lymphadenectomy, number of lymph nodes removed, and radiation therapy seems to increase the risk for LLL. All studies dealing with HQoL show that women with LLL have impaired HQoL. The level of evidence in the published studies is generally low. Consequently it is difficult to make clear-cut conclusions about the true prevalence or determination of risk factors. More prospective longitudinal or randomized trials with LLL as the primary outcome are necessary before conclusions can be drawn regarding prevalence of LLL and risk factor determination in EC. An internationally accepted standardization for terminology and methodology in lymphedema in research is needed.</div></front></TEI><affiliations><list><country><li>Suède</li></country></list><tree><country name="Suède"><noRegion><name sortKey="Lindqvist, Emma" sort="Lindqvist, Emma" uniqKey="Lindqvist E" first="Emma" last="Lindqvist">Emma Lindqvist</name></noRegion><name sortKey="Fredrikson, Mats" sort="Fredrikson, Mats" uniqKey="Fredrikson M" first="Mats" last="Fredrikson">Mats Fredrikson</name><name sortKey="Kj Lhede, Preben" sort="Kj Lhede, Preben" uniqKey="Kj Lhede P" first="Preben" last="Kj Lhede">Preben Kj Lhede</name><name sortKey="Wedin, Madelene" sort="Wedin, Madelene" uniqKey="Wedin M" first="Madelene" last="Wedin">Madelene Wedin</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000417 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000417 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28242470
|texte= Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28242470" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |